An official investigation into a controversial GM rice study carried out with Chinese schoolchildren has resulted in the removal of three China-based researchers.
Daily News Roundup
An official investigation into a controversial GM rice study carried out with Chinese schoolchildren has resulted in the removal of three China-based researchers.
The Cancer Prevention and Research Institute of Texas is under investigation following further concerns about the legitimacy of its grant review process.
A new initiative lead by the UK’s National Health Service aims to sequence the genomes of as many as 100,000 patients, a project that will cost £100 million.
A Chinese biotech company is angling to buy California-based Complete Genomics, but federal regulators are expressing security concerns and may scuttle the deal.
The Supreme Court agrees to hear a case deciding if two cancer genes should continue to be protected by patent.
Without publishing any data, a Texas-based forensic company claims to have sequenced the genome of Bigfoot.
An all-female species, distantly related to flatworms, steals all of genetic material it needs to diversify its genome.
The largest collection of genetic and medical data in the United States links telomeres and genetic variants to longevity and disease.
Biotech, pharmaceutical, and insurance companies have spent a record-breaking amount this election—nearly $200 million.
Retracting a paper from the scientific literature can lead to fewer citations for related studies.